Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8273034rdf:typepubmed:Citationlld:pubmed
pubmed-article:8273034lifeskim:mentionsumls-concept:C0019994lld:lifeskim
pubmed-article:8273034lifeskim:mentionsumls-concept:C0566602lld:lifeskim
pubmed-article:8273034lifeskim:mentionsumls-concept:C0520510lld:lifeskim
pubmed-article:8273034pubmed:issue25lld:pubmed
pubmed-article:8273034pubmed:dateCreated1994-2-2lld:pubmed
pubmed-article:8273034pubmed:abstractTextDuring the period from 1985 to 1993 primary sclerosing cholangitis was diagnosed in 16 patients, five females and 11 males, mean age 43 years. 12 of the patients (75%) had inflammatory bowel disease. Among 262 patients with ulcerative colitis, cholangitis was found in ten, whereas the disease was diagnosed in only two (1.9%) of the 108 patients with Crohn's disease. In eight patients (50%) no progression of the cholangitis was observed. However, six patients (38%) died during the observation period, three 19% due to cholangiocarcinoma and one due to liver failure. Cholangiocarcinoma is frequently found in patients with primary sclerosing cholangitis. A mortality of 38% indicates a serious clinical course in many patients.lld:pubmed
pubmed-article:8273034pubmed:languagenorlld:pubmed
pubmed-article:8273034pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273034pubmed:citationSubsetIMlld:pubmed
pubmed-article:8273034pubmed:statusMEDLINElld:pubmed
pubmed-article:8273034pubmed:monthOctlld:pubmed
pubmed-article:8273034pubmed:issn0029-2001lld:pubmed
pubmed-article:8273034pubmed:authorpubmed-author:AadlandEElld:pubmed
pubmed-article:8273034pubmed:authorpubmed-author:RaknerudNNlld:pubmed
pubmed-article:8273034pubmed:authorpubmed-author:BellHHlld:pubmed
pubmed-article:8273034pubmed:authorpubmed-author:StirisMMlld:pubmed
pubmed-article:8273034pubmed:authorpubmed-author:UtzonPPlld:pubmed
pubmed-article:8273034pubmed:issnTypePrintlld:pubmed
pubmed-article:8273034pubmed:day20lld:pubmed
pubmed-article:8273034pubmed:volume113lld:pubmed
pubmed-article:8273034pubmed:ownerNLMlld:pubmed
pubmed-article:8273034pubmed:authorsCompleteYlld:pubmed
pubmed-article:8273034pubmed:pagination3131-3lld:pubmed
pubmed-article:8273034pubmed:dateRevised2008-7-16lld:pubmed
pubmed-article:8273034pubmed:meshHeadingpubmed-meshheading:8273034-...lld:pubmed
pubmed-article:8273034pubmed:meshHeadingpubmed-meshheading:8273034-...lld:pubmed
pubmed-article:8273034pubmed:meshHeadingpubmed-meshheading:8273034-...lld:pubmed
pubmed-article:8273034pubmed:meshHeadingpubmed-meshheading:8273034-...lld:pubmed
pubmed-article:8273034pubmed:meshHeadingpubmed-meshheading:8273034-...lld:pubmed
pubmed-article:8273034pubmed:meshHeadingpubmed-meshheading:8273034-...lld:pubmed
pubmed-article:8273034pubmed:meshHeadingpubmed-meshheading:8273034-...lld:pubmed
pubmed-article:8273034pubmed:meshHeadingpubmed-meshheading:8273034-...lld:pubmed
pubmed-article:8273034pubmed:meshHeadingpubmed-meshheading:8273034-...lld:pubmed
pubmed-article:8273034pubmed:meshHeadingpubmed-meshheading:8273034-...lld:pubmed
pubmed-article:8273034pubmed:meshHeadingpubmed-meshheading:8273034-...lld:pubmed
pubmed-article:8273034pubmed:year1993lld:pubmed
pubmed-article:8273034pubmed:articleTitle[Primary sclerosing cholangitis. Illustrated by an unselected hospital material].lld:pubmed
pubmed-article:8273034pubmed:affiliationMedisinsk avdeling, Aker sykehus, Oslo.lld:pubmed
pubmed-article:8273034pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8273034pubmed:publicationTypeEnglish Abstractlld:pubmed